# A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate With Leucovorin Protection for Patients With Pneumocystis Carinii Pneumonia.

> **NCT00002102** · NA · COMPLETED · sponsor: **U.S. Bioscience**

## Conditions studied

- Pneumonia, Pneumocystis Carinii
- HIV Infections

## Interventions

- **DRUG:** Trimetrexate glucuronate
- **DRUG:** Leucovorin calcium

## Key facts

- **NCT ID:** NCT00002102
- **Lead sponsor:** U.S. Bioscience
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002102, "A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate With Leucovorin Protection for Patients With Pneumocystis Carinii Pneumonia.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00002102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*